A drop of liquid being dropped into a test tube

Developing predictive in vitro models and testing services to accelerate clinical translation and drug discovery

Find out more

Predictive and functional in vitro tissue models
are the foundation of our assay services

Retina Models

Retinal organoid and pigmented epithelium models for use in modelling of retinopathies, safety studies and therapeutic vector efficacy and safety assessment

Find out more

Kidney Nephron Models

We run toxicity, DDI, transporter assay and cross species comparison studies on our models of the proximal tubule to give you the ability to measure how your drug affects the kidney

Find out more

Lung Airway Models

A suite of airway models that enable drug candidate screening and study of fibrotic disease mechanism, mucociliary clearance and compound efficacy

Find out more

Who we are

We are a team of globally recognised experts in building and applying complex models of human tissues for drug discovery.

We are cell biologists, tissue physiologists, bioegineers and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.

Find out more

What we do

We carry out bespoke efficacy, safety, disease modelling and membrane transporter kinetics studies on our models and provide products that enable customers to generate data to de-risk drug discovery and development.

Our experts collaborate with customers to design studies to provide data that answer their critical questions in pre-clinical drug development. We run the study and provide you with data interpretation or we can supply products for you to run in-house studies.

Find out more

Our Commitment

To improve the success of in vitro to clinical trials translation by developing and validating in vitro models for biomedical research.

We aim to contribute to the development of new innovative therapies by delivering services, products and tools based on our models of human tissues that provide data that informs and predicts how these therapies will behave in humans. Through the wider adoption of this approach, our work will advance the 3R’s policy in drug development.

Find out more

“The extensive scientific knowledge and rigor of Newcells’ staff in the field of ophthalmology as well as their client goal-oriented thinking allowed us to advance quickly in our proof of concept.” Dr Elke Vermassen, Sr. Product Development Manager, KiOmed Pharma

How we innovate to support drug discovery

Build human cell-based in vitro models
Apply our in-depth expertise to design the right study
Provide the data that answers key efficacy, safety or transport questions
Provide the tool or assay for customer in-house studies
Timely delivery of data to fit with customers deadlines

How we work with you

Newcells mission is to de-risk the decision-making process in drug development by providing physiologically relevant in vitro models that most accurately predict in vivo outcomes.

Globally recognised scientific expertise in cell physiology and organoid technology is embedded in all products & services. We engineer in vitro models from primary tissues and iPSCs to accelerate drug discovery and improve clinical translation.

About us